CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 32555-32764 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T222","span":{"begin":0,"end":209},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Nevertheless, the use of MxA as a biological marker for IFNb treatment in multiple sclerosis (MS) has been criticized for the lack of evidence of its role on disease pathogenesis and clinical response to IFNb."}

{"project":"Epistemic_Statements","denotations":[{"id":"T75","span":{"begin":0,"end":209},"obj":"Epistemic_statement"}],"text":"Nevertheless, the use of MxA as a biological marker for IFNb treatment in multiple sclerosis (MS) has been criticized for the lack of evidence of its role on disease pathogenesis and clinical response to IFNb."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T222","span":{"begin":0,"end":209},"obj":"Sentence"}],"text":"Nevertheless, the use of MxA as a biological marker for IFNb treatment in multiple sclerosis (MS) has been criticized for the lack of evidence of its role on disease pathogenesis and clinical response to IFNb."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T129","span":{"begin":94,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A129","pred":"uberon_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Nevertheless, the use of MxA as a biological marker for IFNb treatment in multiple sclerosis (MS) has been criticized for the lack of evidence of its role on disease pathogenesis and clinical response to IFNb."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T42990","span":{"begin":74,"end":92},"obj":"Disease"},{"id":"T77813","span":{"begin":94,"end":96},"obj":"Disease"},{"id":"T64356","span":{"begin":74,"end":92},"obj":"Disease"},{"id":"T11854","span":{"begin":94,"end":96},"obj":"Disease"}],"attributes":[{"id":"A14914","pred":"mondo_id","subj":"T42990","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A83469","pred":"mondo_id","subj":"T77813","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A55172","pred":"mondo_id","subj":"T64356","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A22481","pred":"mondo_id","subj":"T11854","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"Nevertheless, the use of MxA as a biological marker for IFNb treatment in multiple sclerosis (MS) has been criticized for the lack of evidence of its role on disease pathogenesis and clinical response to IFNb."}